SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Nabi (NABI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Extra Pale who wrote (284)9/23/2000 9:06:46 AM
From: Oak Tree  Read Replies (1) of 354
 
Mike, regarding NABI staph vaccine. That data might also suggest that the patients will need multiple vacinations (like for yellow feaver and stuff). Some vaccines aren't permanent. Are they planing another study with multiple vaccinations? Didn't they recently have a private offer of $10M at about $7 per share? Those people must have known that the supply of reagents was low and that sales would be off? Anyway I'm back in at 6 and below hoping for at least 7 in the short term. If indeed only reagents were low, and assuming reagents will not be low in the future, sales should still be there.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News